🇺🇸 FDA
Pipeline program

Sativex

GWCL0403

Approved small_molecule completed

Quick answer

Sativex for Multiple Sclerosis is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Multiple Sclerosis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials